Global, regional, and national prevalence and mortality burden of sickle cell disease, 2000–2021: a systematic analysis from the Global Burden of Disease Study 2021
Summary
Background Previous global analyses, with known underdiagnosis and single cause per death attribution systems, provide only a small insight into the suspected high population health effect of sickle cell disease. Completed as part of the Global Burden of Diseases, Injuries, and Risk Factors Study (GBD) 2021, this study delivers a comprehensive global assessment of prevalence of sickle cell disease and mortality burden by age and sex for 204 countries and territories from 2000 to 2021.
[pdf-embedder url=”https://awgp.pt/wp-content/uploads/2023/10/Global-regional-and-national-prevalence-and-mort.pdf” title=”Global,-regional,-and-national-prevalence-and-mort”]
[pdf-embedder url=”https://awgp.pt/wp-content/uploads/2023/10/Sickle-cell-diseasex2014unity-and-patient-centr.pdf” title=”Sickle-cell-disease—unity-and-patient-centr”]
[pdf-embedder url=”https://awgp.pt/wp-content/uploads/2023/10/Correction-to-em-Lancet-Haematol-em-2023-10-e.pdf” title=”Correction-to–em-Lancet-Haematol–em–2023;-10–e”]